45 studies found for:    Open Studies | "Alopecia"
Show Display Options
Rank Status Study
21 Recruiting An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: Abatacept
22 Recruiting Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss
Condition: Androgenetic Alopecia
Interventions: Dietary Supplement: HCap Formula;   Dietary Supplement: Placebo
23 Recruiting Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Device: topical 5% Minoxidil (Microneedling)
24 Not yet recruiting Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Device: PRGF-Endoret;   Other: Saline Solution
25 Recruiting Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10);   Device: Restylane
26 Recruiting Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: Interleukin-2
27 Recruiting The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement
Condition: Female Pattern Alopecia
Interventions: Drug: 15 mg Chelate zinc supplement;   Drug: Placebo drug supplement
28 Recruiting 24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness
Condition: Androgenetic Alopecia
Interventions: Device: iRestore Hair Rejuvenation System;   Device: sham device
29 Recruiting Effect of PRP on the Therapy for Hair Growth
Condition: Hair Loss/Baldness
Intervention: Other: hair loss, baldness (patient's own platelet-rich plasma)
30 Recruiting Treatment of Androgenetic Alopecia in Males and Females
Condition: Androgenetic Alopecia
Interventions: Device: TopHat 655 rejuvenation system;   Device: Laser and/or Light Hair Rejuvenation System
31 Recruiting Safety and Efficacy of Nitric Oxide Gel in Promoting Hair Growth in Male Human Subjects With Androgenetic Alopecia
Condition: Alopecia Androgenica
Interventions: Other: Nitric Oxide (NO) Gel;   Other: Placebo gel
32 Unknown  Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss
Condition: Female Pattern Hair Loss
Interventions: Drug: Spironolactone;   Drug: Minoxidil
33 Not yet recruiting Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
Conditions: Alopecia;   Breast Cancer
Interventions: Drug: bimatoprost ophthalmic solution;   Drug: placebo
34 Unknown  Hair Regrowth After Bicoronal Incision
Condition: Alopecia
Interventions: Procedure: Straight Incision;   Procedure: Bevelled Incision
35 Unknown  Split Wound Comparison of Trichophytic Closure Techniques for Donor Site in Hair Transplantation
Condition: Androgenetic Alopecia
Interventions: Procedure: Trichophytic closure upper edge trimming;   Procedure: Trichophytic closure lower edge trimming;   Procedure: Trichophytic closure both edge trimming
36 Not yet recruiting The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade
Condition: ALOPECIA AREATA
Intervention: Drug: Methotrexate
37 Recruiting Androgenetic Alopecia in Fabry Disease
Condition: Fabry Disease
Intervention:
38 Unknown  Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer
Condition: Breast Cancer
Intervention:
39 Unknown  Efficacy and Safety Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Androgenetic Alopecia
Conditions: Objective (Goal);   Self-Assessment;   Adverse Effects
Interventions: Drug: 5% MInoxidil milky lotion;   Drug: 5% Minoxidil solution
40 Recruiting Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results
Indicates status has not been verified in more than two years